Fundraising Fox
Inventure
also invests · investor profileHelsinki, FI · Founded 2005 · 36 employees on LinkedIn · 10 known investors
Find your way into Inventure
Sign up to see every warm intro you have to Inventure
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inventure team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Inventure is a generalist venture capital firm investing primarily in Nordic and Baltic companies across deep tech, consumer, healthtech, AI, and B2B SaaS sectors. Founded in 2005, the firm has backed over 100 portfolio companies.
Also known as Inventure · Inventure Oy · Inventure VC
Founders & leadership
Board
Investors · 10
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6.1M disclosed across 12 rounds · 2015–2026
▶$82.3KraisedSep 2026 · 4 investors · PharmaceuticalsRule 506(b)
- Richard DeslauriersDirector
- Offering amount
- $82.3K
- Amount sold
- $82.3K
- Minimum investment
- $7.3K
- First sale
- Aug 2026
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$200KraisedFeb 2026 · 4 investors · PharmaceuticalsRule 506(b)
- Richard DeslauriersDirector
- Offering amount
- $200K
- Amount sold
- $200K
- Minimum investment
- $50K
- First sale
- Feb 2026
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$361.5KraisedJul 2025 · 6 investors · PharmaceuticalsRule 506(b)
- Kyle SalemExecutive Officer
- Brad RummerDirector
- Richard DeslauriersDirector
- Offering amount
- $361.5K
- Amount sold
- $361.5K
- Minimum investment
- $10K
- First sale
- Jul 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$250KraisedAug 2023 · 5 investors · PharmaceuticalsRule 506(b)
- Richard J DeslauriersDirector
- Offering amount
- $250K
- Amount sold
- $250K
- Minimum investment
- $25K
- First sale
- Jul 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedMar 2023 · 5 investors · PharmaceuticalsRule 506(b)
- Richard J DeslauriersDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Minimum investment
- $25K
- First sale
- Aug 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1MraisedSep 2021 · 1 investors · PharmaceuticalsRule 506(b)
- Richard J DeslauriersDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- First sale
- Sep 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$45KraisedJan 2021 · 8 investors · PharmaceuticalsRule 506(b)
- Richard J DeslauriersDirector
- Brad RummerDirector
- Offering amount
- $45K
- Amount sold
- $45K
- Minimum investment
- $45K
- First sale
- Dec 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$350KraisedMar 2020 · 9 investors · PharmaceuticalsRule 506(b)
- Robert F. JacobsExecutive Officer
- Richard J. DeslauriersDirector
- Brad RummerDirector
- Offering amount
- $500K
- Amount sold
- $350K
- Minimum investment
- $50K
- First sale
- Dec 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Inventure is an early-stage venture capital firm that backs founders primarily in the Nordics and Baltics. Operating since 2005, it describes itself as a generalist investor and says it has backed over 100 companies across deep tech, consumer, healthtech, AI and B2B SaaS. Its stated focus is on seed-stage investment, with third-party profiles also citing early-stage and Series A activity, and investment amounts placed in a roughly EUR 100k to EUR 10M range over a company's lifecycle.
The firm's publicly listed portfolio spans consumer marketplaces and brands (Wolt, Swappie), insurtech (Lassie, Omocom, Insurello), healthtech and biotech (Medoma, Blueprint Genetics, Samphire Neuroscience, biomatter, MONCYTE Health), deep tech and space (Algorithmiq, ReOrbit, Umbra, Canatu, Wirepas), B2B software (Stravito, Scoro, Detectify, Whatagraph, Hopsworks, Codescene, Klevu) and gaming (Mindfield Games, Like a Boss Games, Sólfar Studios). Portfolio companies are located in countries including Finland, Sweden, Lithuania and Hungary.
In 2025 Inventure marked its 20th year and introduced a refreshed brand identity developed with the agency Bedow, alongside a restated thesis emphasizing high selectivity and backing founders rather than ideas.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 6
launches, deals, and filingsInventure announced Cristina Koehn as its new Chief Operating Officer.
Inventure announced Sophie Mattsson as a new Investment Associate.
Inventure reported that Monterro acquired a majority stake in portfolio company Kaisa.
Inventure published a refreshed visual identity and brand positioning developed with the brand agency Bedow, coinciding with the firm's 20th year.
Inventure announced backing Samphire Neuroscience, a women's health company focused on PMS and PMDD.
Inventure announced the closing of its fourth fund with commitments of EUR 150 million.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structure▸Research sources · 7
primary sources listed
- Inventureinventure.fi · web
- Inventure Company Profile: Financials, Valuation, and Growth | PrivCoprivco.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Inventure do?
- Nordic and Baltic seed-stage venture capital firm, founded 2005 and headquartered in Helsinki.
- Who are Inventure's investors?
- Inventure's investors include Butterfly Ventures, Balderton Capital, CDP Venture Capital, FELIX CAPITAL, Metaplanet, Passion Capital, Stena Sessan, Superhero Capital and 2 more.
- How much funding has Inventure raised?
- Inventure has disclosed $6.1M raised across 12 rounds.
- Where is Inventure headquartered?
- Inventure is headquartered in Helsinki, FI.